302 - Trial of Bapineuzumab in Patients with Mild to Moderate AD who are Apolipoprotein E4 Epsilon4 CARRIERS

  • Jicha, Gregory (PI)
  • Caban-Holt, Allison (CoI)
  • Freeman, Stephanie (CoI)
  • Hamon, Robin (CoI)
  • Howe, Jeffrey (CoI)
  • Smart, Marie (CoI)
  • Smith, Charles (CoI)
  • Turner, Karin (CoI)
  • Cooper, Gregory (Former CoI)
  • Newsham, Patrick (Former CoI)

Grants and Contracts Details

Effective start/end date12/1/104/30/13


  • Janssen Alzheimer Immunotherapy Research and Development LLC: $122,734.00